Literature DB >> 1087154

IgG antilymphocyte antibodies in SLE detected by 125I protein A.

R C Williams, A D Bankhurst, J D Montaño.   

Abstract

125I-labeled protein A was utilized to detect lymphocyte binding of IgG at 37 degrees C in 50 sera from patients with SLE. IgG binding was partially inhibited by preincubation of test cells with immune complexes in 50% of sera. In 10%, cytophilic Ig was increased by immune complex preincubation, and in 40% no appreciable change was recorded. With purified preparations of T and B cells, binding of SLE IgG at 37 degrees C was equal for both cell populations.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1087154     DOI: 10.1002/art.1780190606

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  9 in total

Review 1.  Systemic lupus erythematosus--an autoimmune disease?

Authors:  E J Holborow
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1978

Review 2.  Immune complexes in human diseases: a review.

Authors:  A N Theofilopoulos; F J Dixon
Journal:  Am J Pathol       Date:  1980-08       Impact factor: 4.307

Review 3.  Antibodies to CD45 and other cell membrane antigens in systemic lupus erythematosus.

Authors:  J B Winfield; P Fernsten; J Czyzyk; E Wang; J Marchalonis
Journal:  Springer Semin Immunopathol       Date:  1994

Review 4.  Lymphocytotoxic antibodies in SLE: a review of the literature.

Authors:  C Osman; A J Swaak
Journal:  Clin Rheumatol       Date:  1994-03       Impact factor: 2.980

5.  Immune complexes in congenital and natal cytomegalovirus infections of man.

Authors:  S Stagno; J E Volanakis; D W Reynolds; R Stroud; C A Alford
Journal:  J Clin Invest       Date:  1977-10       Impact factor: 14.808

6.  Absence of IgG lymphocytotoxins in untreated Hodgkin's disease (HD) patients.

Authors:  D B Jones; E V Elliott; S V Payne; D H Wright
Journal:  Clin Exp Immunol       Date:  1978-10       Impact factor: 4.330

7.  Lymphocyte destruction by antibody-dependent cellular cytotoxicity mediated in vitro by antibodies in serum from patients with systemic lupus erythematosus.

Authors:  M L Mahowald; A P Dalmasso
Journal:  Ann Rheum Dis       Date:  1982-12       Impact factor: 19.103

8.  Lymphocyte antigens in systemic lupus erythematosus: studies with heterologous antisera.

Authors:  R C Williams; G R Hughes; M L Snaith; H F Parry; E Diao; M F Greaves
Journal:  J Clin Invest       Date:  1980-02       Impact factor: 14.808

9.  Inhibition of soluble antigen-induced T cell proliferation by warm-reactive antibodies to activated T cells in systemic lupus erythematosus.

Authors:  A Yamada; J B Winfield
Journal:  J Clin Invest       Date:  1984-12       Impact factor: 14.808

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.